[1-(2-hydroxy-2-methylbutyl)-3-methylcyclohexyl] 2,4-dimethyl-2-propan-2-yl-4-sulfanylpentanoate
C22H42O3S — CID 175624390
Data last refreshed: (MolForge compound catalog, from PubChem)
About [1-(2-hydroxy-2-methylbutyl)-3-methylcyclohexyl] 2,4-dimethyl-2-propan-2-yl-4-sulfanylpentanoate
[1-(2-hydroxy-2-methylbutyl)-3-methylcyclohexyl] 2,4-dimethyl-2-propan-2-yl-4-sulfanylpentanoate (PubChem CID 175624390) has the molecular formula C22H42O3S and a molecular weight of 386.64 g/mol. Its IUPAC name is [1-(2-hydroxy-2-methylbutyl)-3-methylcyclohexyl] 2,4-dimethyl-2-propan-2-yl-4-sulfanylpentanoate.
Molecular Properties
| Compound Name | [1-(2-hydroxy-2-methylbutyl)-3-methylcyclohexyl] 2,4-dimethyl-2-propan-2-yl-4-sulfanylpentanoate |
|---|---|
| PubChem CID | 175624390 |
| Molecular Formula | C22H42O3S |
| Molecular Weight | 386.64 g/mol |
| Exact Mass | 386.29 |
| IUPAC Name | [1-(2-hydroxy-2-methylbutyl)-3-methylcyclohexyl] 2,4-dimethyl-2-propan-2-yl-4-sulfanylpentanoate |
| SMILES | CCC(C)(O)CC1(OC(=O)C(C)(CC(C)(C)S)C(C)C)CCCC(C)C1 |
| InChI | InChI=1S/C22H42O3S/c1-9-20(7,24)15-22(12-10-11-17(4)13-22)25-18(23)21(8,16(2)3)14-19(5,6)26/h16-17,24,26H,9-15H2,1-8H3 |
| InChIKey | VTCXNASPCLWHQF-UHFFFAOYSA-N |
| XLogP | 5.79 |
| TPSA | 46.53 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 386.64 |
| LogP ≤ 5 | 5.79 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'thiol_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175624390 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.